After Win, FDA May Backtrack On More Device Approvals

Law360, New York (April 29, 2013, 9:30 PM EDT) -- Earlier this month, a federal judge backed the U.S. Food and Drug Administration's decision to revoke its marketing clearance for a knee implant more than two years after it had initially granted it, a ruling that attorneys worry may embolden the agency to make similar retractions on other medical devices.

U.S. District Judge Robert Wilkins granted the FDA summary judgment April 10 in a suit brought by ReGen Biologics Inc., after the agency decided to rescind its clearance of ReGen's Menaflex knee implant.

The FDA had...
To view the full article, register now.